CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma

David Martin‐García(Centro de Investigación Biomédica en Red de Cáncer), Sı́lvia Beà(Departament de Salut), Susanne Bens(Universität Ulm), Daphne de Jong(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Judith A. Ferry(Harvard University), Fina Climent, Luis Veloza(Hospital Clínic de Barcelona), Steven H. Swerdlow(University of Pittsburgh), Dennis D. Weisenburger(University of Nebraska Medical Center), Eric D. Hsi(Mayo Clinic), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Elı́as Campo(Hospital Clínic de Barcelona), Leticia Quintanilla‐Martínez(University Children's Hospital Tübingen), Reiner Siebert(Christian-Albrechts-Universität zu Kiel), Blanca González‐Farré(Hospital Clínic de Barcelona), Jesús Gutiérrez‐Abril(Universidad de Oviedo), Grzegorz Rymkiewicz(The Maria Sklodowska-Curie National Research Institute of Oncology), Blanca Espinet(Hospital Del Mar), Inmaculada Ribera‐Cortada(University of Andorra), Sergi Beltrán(Centro Nacional de Análisis Genómico), Renata Woroniecka, Dolors Costa(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Itziar Salaverría(Centro de Investigación Biomédica en Red de Cáncer), Laurence de Leval(University Hospital of Lausanne), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Sheila J.M. O’Connor(Leeds Teaching Hospitals NHS Trust), Estella Matutes(Institute of Cancer Research), Rafael Valdés‐Mas(Weizmann Institute of Science), Jan Delabie, Miriam Prieto(Centro de Investigación Biomédica en Red de Cáncer), David Torrents(Barcelona Supercomputing Center), Carlos López-Otı́n(Inserm), Elaine S. Jaffe(National Cancer Institute), Xosé S. Puente(Universidad de Oviedo), Kai Fu(Soochow University), Alba Navarro(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Guillem Clot(Aristotle University of Thessaloniki)
Blood
December 11, 2018
Cited by 112


Related Papers